Device type · DIO
Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DIO
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
12
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Enzyme Immunoassay, Cocaine And Cocaine Metabolites
- Product code
- DIO
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3250
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DIO
Latest FDA decisions
The 8 newest of 12 since 2015.
- Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System510(k)
Carolina Liquid Chemistries Corp.
K213211 · Decided Jan 27, 2022 · 120 days after receipt
Device type: Enzyme Immunoassay, Cocaine And Cocaine Metabolites (DIO) · Laboratory Medicine & Pathology
K211973 · Decided Sep 24, 2021 · 91 days after receipt
Device type: Enzyme Immunoassay, Cocaine And Cocaine Metabolites (DIO) · Laboratory Medicine & Pathology
K191638 · Decided Mar 12, 2020 · 267 days after receipt
Device type: Enzyme Immunoassay, Cocaine And Cocaine Metabolites (DIO) · Laboratory Medicine & Pathology
9 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3029-2020 · Started Aug 18, 2020
Reason given: Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Cause as FDA categorized it: Process control
Z-3030-2020 · Started Aug 18, 2020
Reason given: Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Cause as FDA categorized it: Process control
Z-3031-2020 · Started Aug 18, 2020
Reason given: Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Cause as FDA categorized it: Process control
20 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.